 |
|
|
|
|
Washington Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2022 replacing WashingtonLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Universal Cells Inc.
| | | | | Phone: | (206) 829-8901 | | Year Established: | 2014 | | Employees: | 4 | | Main Contact: | Claudia Mitchell Ph.D. MBA, CEO | | | | Other Contacts: | David Russell M.D. Ph.D., CSO
Gregory Block M.Sc. Ph.D., VP, Business Development
| | | | Company Description | Universal Cells is a development stage company based on intellectual property developed at the University of Washington, and includes methods for genome editing in human stem cells via homologous recombination with recombinant adeno-associated virus (rAAV) vectors.
Astellas Pharma and Universal Cells announced that Astellas has acquired Universal Cells. Astellas paid $102.5 million upfront and milestones to acquire 100 percent ownership of Universal Cells depending on achievement of certain specified clinical milestones. | |
|
|
|
|
|
|
|
